Axonics Q2 EPS $(0.15) Misses $(0.11) Estimate, Sales $92.89M Beat $86.51M Estimate
Portfolio Pulse from Benzinga Newsdesk
Axonics (NASDAQ:AXNX) reported Q2 losses of $(0.15) per share, missing the analyst consensus estimate of $(0.11) by 36.36%. However, the company's quarterly sales of $92.89 million beat the analyst consensus estimate of $86.51 million by 7.38%. This represents a 34.67% increase over sales from the same period last year.
July 27, 2023 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Axonics reported Q2 losses greater than expected but beat sales estimates.
Axonics' Q2 earnings report is a mixed bag. While the company missed EPS estimates, it beat sales estimates. This could lead to a neutral short-term impact on the stock as investors weigh the positive and negative aspects of the report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100